Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: Azithromycin Reduction to Reach Elimination of Trachoma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating strategies to reduce azithromycin use toward elimination of trachoma; the study has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Trachoma | Phase 4 | Status: COMPLETED | Results posted: 2026-03-25